Regina Dugan - Varian Medical Independent Director
Director
Dr. Regina E. Dugan serves as Independent Director of the Company. She served as Vice President of Engineering, Facebook, Inc., Vice President of Engineering at Google, Inc., a global technology company, leading the Advanced Technology and Products group, a research and development organization of the U.S. Department of Defense, CoFounder, President and Chief Executive Officer, RedXDefense LLC, a security solutions company. She is CoFounder, President and Chief Executive Officer, Dugan Ventures, an investment firm, Other Current Public Company Board Memberships Zynga Inc., a social game developer. since 2013.
| Age | 56 |
| Tenure | 11 years |
| Professional Marks | Ph.D |
| Phone | 650 493-4000 |
| Web | www.varian.com |
Varian Medical Management Efficiency
The company has Return on Asset of 5.92 % which means that on every $100 spent on assets, it made $5.92 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 13.51 %, implying that it generated $13.51 on every 100 dollars invested. Varian Medical's management efficiency ratios could be used to measure how well Varian Medical manages its routine affairs as well as how well it operates its assets and liabilities.Varian Medical Systems has 350.5 M in debt with debt to equity (D/E) ratio of 0.16, which may show that the company is not taking advantage of profits from borrowing. Varian Medical Systems has a current ratio of 1.48, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Varian to invest in growth at high rates of return.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Ronald Waters | HNI Corp | 69 | |
| Yoseph Bornstein | Microbot Medical | 65 | |
| Mary Jones | HNI Corp | 52 | |
| Cheryl Francis | HNI Corp | 67 | |
| Pedro Sousa | Braskem SA Class | 45 | |
| Brian Stern | HNI Corp | 71 | |
| Miguel Calado | HNI Corp | 65 | |
| John Hartnett | HNI Corp | 60 | |
| Mary Bell | HNI Corp | 60 | |
| Abbie Smith | HNI Corp | 67 | |
| Fabio Venturelli | Braskem SA Class | 54 | |
| Larry Porcellato | HNI Corp | 62 | |
| Pedro Carvalho | Braskem SA Class | N/A | |
| Dhanusha Sivajee | HNI Corp | 43 | |
| Inge Vanwittenbergh | Nyxoah | N/A | |
| Gesner Oliveira | Braskem SA Class | 63 | |
Management Performance
| Return On Equity | 13.51 | |||
| Return On Asset | 5.92 |
Varian Medical Systems Leadership Team
Elected by the shareholders, the Varian Medical's board of directors comprises two types of representatives: Varian Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Varian. The board's role is to monitor Varian Medical's management team and ensure that shareholders' interests are well served. Varian Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Varian Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeffrey Balser, Independent Director | ||
| R Eckert, Independent Chairman of the Board | ||
| Regina Dugan, Independent Director | ||
| David Illingworth, Independent Director | ||
| Judy Bruner, Independent Director | ||
| Kolleen Kennedy, Executive Vice President, President - Proton Solutions Division and Chief Growth Officer | ||
| J Bruff, Chief Financial Officer, Senior Vice President - Finance | ||
| Christopher Toth, President, Chief Executive Officer, Chief Operating Officer | ||
| Michael Hutchinson, Senior Vice President, Chief Legal Officer, Corporate Secretary | ||
| Anat Ashkenazi, Independent Director | ||
| Phillip Febbo, Chief Medical Officer, Director | ||
| JeanLuc Butel, Independent Director | ||
| Kevin OReilly, Senior Vice President and President Oncology Systems | ||
| Chris Toth, President - Varian Oncology Systems | ||
| Dow Wilson, President, Chief Executive Officer, Director | ||
| Michelle Beau, Independent Director | ||
| Francis Facchini, President Interventional Solutions Business |
Varian Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Varian Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 13.51 | |||
| Return On Asset | 5.92 | |||
| Profit Margin | 8.90 % | |||
| Operating Margin | 16.82 % | |||
| Current Valuation | 15.86 B | |||
| Shares Outstanding | 91.84 M | |||
| Shares Owned By Insiders | 0.29 % | |||
| Shares Owned By Institutions | 86.66 % | |||
| Number Of Shares Shorted | 2.6 M | |||
| Price To Earning | 58.41 X |
Pair Trading with Varian Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Varian Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Varian Medical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Nucor Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nucor Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nucor Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nucor Corp to buy it.
The correlation of Nucor Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nucor Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nucor Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nucor Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Varian Stock
If you are still planning to invest in Varian Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Varian Medical's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |